Meghna Deshraj

In this episode, Len May, CEO of EndoDNA, joins Heath Fletcher to explore the future of personalized medicine through genetic testing. They dive into the challenges of innovating within the healthcare market, the role of lifestyle and genetics in preventative care, and the critical importance of understanding the endocannabinoid system. Len shares personal stories that highlight the transformative potential of precision health, the need to overcome stigma around cannabis, and the power of partnerships in driving research. The conversation also reflects on mentorship, personal influences, and how music shapes both life and work.Guest Information:Guest's Name: Len MayGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/lenmay/ Company/Affiliation: EndoDNAGuest's Bio: Len May is a pioneer in personalized wellness, combining over 25 years of experience in genomics, epigenetics, and the endocannabinoid system. As the CEO of EndoDNA, he leads the development of a patented platform that uses DNA to deliver personalized health insights, supported by the world’s largest real-world efficacy dataset. A global authority on medicinal cannabis and precision health, Len is also a published author, international speaker, and host of the podcast Everything is Personal. His books Making Cannabis Personal and ADD is a Superpower highlight his commitment to reshaping healthcare through personalization. Len’s work continues to shape the future of individualized medicine, making healthcare truly personal.Links and Resources:Podcast: Everything is Personal Books: Making Cannabis Personal / ADD is a SuperpowerWebsite: https://www.lenmaycoaching.com/

In this episode, Heath Fletcher sits down with Dr. Jay Sanders, the “Father of Telemedicine,” to explore how technology is reshaping healthcare. From the early days of telemedicine to the integration of AI and electronic medical records, Dr. Sanders shares his visionary insights on the future of medicine. They discuss the economic impact on rural hospitals, the importance of cybersecurity, and why anticipatory, patient-driven care is key to the next evolution in healthcare.Chapters00:00 Introduction to Jay Sanders and Telemedicine05:05 The Evolution of Telemedicine10:02 Economic Impact of Telemedicine on Rural Healthcare15:04 The Role of AI in Medicine20:12 Current Work and Future of Telemedicine25:06 The Future of Healthcare: Anticipatory Medicine27:55 Leveraging Technology for Patient Care30:02 AI in Medical Decision Making31:59 Cybersecurity in Healthcare Data34:10 The Future of Healthcare Post-Pandemic41:01 Innovations in Telemedicine and AI45:57 The Vision for Future HealthcareGuest Information:Guest's Name: Dr. Jay H. SandersGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/jay-sanders-m-d-9618771/.  Company/Affiliation: The Global Telemedicine GroupGuest's Bio: Dr. Jay H. Sanders, known as the “Father of Telemedicine,” is the CEO of The Global Telemedicine Group and Adjunct Professor of Medicine at Johns Hopkins. He founded the American Telemedicine Association and pioneered numerous telemedicine innovations, including the first statewide system and telemedicine kiosk. A Harvard Medical School graduate and former Chief Medical Resident at Massachusetts General Hospital, Dr. Sanders has advised organizations like NASA, DOD, WHO, and the White House. His career spans groundbreaking work in digital health, policy, and global telemedicine strategy.Links and Resources:Co-Author of the Book Digital Medical HomeAvailable on Amazon: https://www.amazon.ca/Digital-Medical-Home-Telemedicine-Revolution/dp/B0BRDDJGKYTakeawaysThe term 'telemedicine' was coined in 1969 during a project at Massachusetts General Hospital.Telemedicine can significantly improve healthcare access in rural areas.Economic factors play a crucial role in the sustainability of rural hospitals.AI has the potential to surpass human physicians in certain areas of healthcare.The best examination of a patient occurs in their home environment.Telemedicine has evolved from using microwave antennas to modern telecommunications.COVID-19 accelerated the acceptance and payment for telemedicine services.Healthcare needs to shift from reactionary to anticipatory models.Genetic analysis should be integrated into routine healthcare practices. Leveraging technology can significantly improve patient care.AI can assist in making informed medical decisions.Cybersecurity is a critical concern for healthcare data.The pandemic has accelerated changes in healthcare delivery.Patients need to take more responsibility for their health.Telemedicine is becoming a standard practice in healthcare.Integrating genetics into healthcare can enhance treatment specificity.Healthcare systems must adapt to new technologies for better outcomes.Access to healthcare is essential, but accuracy is equally important.The future of healthcare will rely on innovative technologies and patient engagement.

In this episode, Dan Goldberger, CEO of electricCore, explores the company’s innovative use of non-invasive vagus nerve stimulation to treat conditions such as headaches, PTSD, and other medical issues. He emphasizes the strong safety profile of their technology and its potential in the growing field of bioelectronic medicine. Dan explains the foundational concept of the body’s electrical systems and how bioelectronics offer an alternative to traditional pharmaceuticals. He also shares perspectives on leadership, company culture, and the challenges of marketing in healthcare, along with thoughts on the role of AI and automation in the future of health tech and personal career insights.Special Podcast Offer: 10% truvaga discount code HEALTH1000:00Introduction to Electric Core and Its Innovations04:48Understanding Vagus Nerve Stimulation10:00The Impact of Headaches and PTSD15:02Leadership Lessons and Building Culture19:59The Future of Bio-Electronic Medicine21:06The Electrical Nature of the Human Body28:29Marketing Evolution in Healthcare33:59Navigating AI and Automation in Health Tech37:32Reflections on Career and Life LessonsGuest Information:Guest's Name: Dan GoldbergerGuest's Title/Position: Chief Executive Officerhttps://www.linkedin.com/in/goldbergerdan/Company/Affiliation: electroCoreGuest's Bio: Dan Goldberger is a highly accomplished C-level executive with over 25 years of leadership experience, known for driving revenue growth and organizational success in the life sciences and healthcare sectors. He has built a strong reputation for leading turnaround initiatives, cultivating high-performance cultures, and spearheading product innovation in competitive, highly regulated industries including biotech, high tech, and medical technology. Links and Resources:electroCore Website: https://www.electrocore.com/Special Podcast Offer: 10% truvaga discount code HEALTH10Key TakeawaysThe company offers products for treating headaches and is expanding into PTSD treatment.Vagus nerve stimulation has a wide range of potential applications in medicine.The technology has a benign safety profile with minimal side effects.Leadership is about surrounding yourself with the right people and building a strong culture.Listening is a crucial skill for effective leadership and learning.Embracing change is essential for resilience in business.The future of bio-electronic medicine is promising and innovative.Dan emphasizes the importance of leading by example in building company culture.The conversation highlights the liberating potential of electricCore's products for patients. The human body operates as an electrical machine.Bioelectronics is an emerging field in healthcare.The vagus nerve plays a crucial role in balance.Stimulating the vagus nerve can restore homeostasis.Marketing in healthcare is increasingly complex.AI is not yet a strategic focus for their company.Direct consumer access to health tech is growing.Ethics and morality are vital in business.Career reflections emphasize the importance of relationships.Helping others is the core motivation in health tech.

In this conversation, Heath Fletcher and Real Rousseau explore the concept of fractional management, particularly in the context of C-suite roles. Real shares his extensive background in engineering and business management, discussing how fractional executives can provide expertise at a fraction of the cost of full-time hires. The discussion covers the benefits of fractional engagement, the differences between fractional executives and consultants, and the strategic planning processes that fractional executives can help implement. Real emphasizes the importance of structure in creativity and how fractional executives can help businesses grow by providing accountability and expertise.Chapters00:00Introduction to Fractional Management02:56The Rise of Fractional Executives05:57Benefits of Fractional C-Suite Engagement08:59Identifying the Right Time for Fractional Support11:59Strategic Planning and Implementation14:49The Role of Fractional Executives in Growth18:02Leveraging Experience Across Industries20:57Conclusion and Future of Fractional ManagementGuest Information:Guest's Name: Real RousseauGuest's Title/Position: Chief Strategy Officerhttps://www.linkedin.com/in/real-rousseau-5b150422/Company/Affiliation: Bullzeye Media MarketingGuest's Bio: Real Rousseau is a seasoned business growth strategist with over 20 years of executive leadership experience spanning CEO, COO, and Business Development roles. He specializes in helping companies unlock revenue potential, streamline operations, and lead high-performing sales and marketing teams. Known for delivering measurable results—such as doubling revenue and boosting profit margins by 30% in just 12 months—Real combines strategic vision with operational expertise to drive sustainable business success.TakeawaysFractional management offers executive expertise at a lower cost.The rise of fractional executives coincided with the COVID-19 pandemic.Fractional executives are part of the team, unlike consultants.Hiring junior staff may not always provide the needed expertise.Fractional executives can help identify when a business needs support.Strategic planning is crucial for business growth and accountability.Fractional executives can help implement financial processes and budgeting.AI tools can assist but cannot replace the need for human expertise.Fractional roles can evolve as the business grows and changes.Collaboration between fractional executives and business owners enhances growth.

In this episode, we interview David Esposito, an experienced healthcare CEO with a background in both large pharma and early-stage biotech. David discusses his career journey, insights into leading and scaling healthcare companies, and the challenges and opportunities in developing innovative therapies for diseases of the eye. He also shares his perspective on leadership, team building, and the importance of maintaining a focus on patient outcomes.Chapters/Timestamps:00:00 - Introduction and David Esposito's Background02:09 - ONL Therapeutics and its Focus09:05 - David Esposito’s Career Journey24:47 - Leadership and Team Building32:35 - Challenges in Biotech and Company Growth48:22 - Marketing and Clinical Trial Enrollment58:52 - Funding and Future Outlook1:09:09 - Inspiration and Advice1:19:31 - The Future of Healthcare InnovationGuest Information:Guest's Name: David EspositoGuest's Title/Position: CEOCompany/Affiliation: ONL TherapeuticsGuest's Bio: David Esposito is an experienced healthcare CEO with over thirty years in the industry. He has a background in large pharma and has built and scaled multiple early to mid-stage life science companies. Currently, he is the CEO of ONL Therapeutics, a mid-stage biotech company focused on developing therapies for diseases of the eye.Links and Resources:ONL Therapeutics: https://onltherapeutics.com/RA Capital: https://www.racap.com/Andreessen Horowitz: https://a16z.com/

In this episode, we interview Dr. Alena Butkevica, an oro maxillofacial surgeon and the CEO and lead researcher at AB Bio Innovations. Dr. Butkevica shares her journey from reconstructive surgery to developing a line of skincare products designed to boost natural body regeneration and provide alternatives to invasive procedures. She discusses the science behind her products, the importance of high-quality ingredients, and her passion for helping people achieve healthy skin.Chapters/Timestamps:00:00 - Introduction and Dr. Alena Butkevica's Background    10:00 - Dr. Alena Butkevica's Career and Surgical Experience    37:00 - Explanation of Circulation and the Effects of Aging    55:00 - Development of AB Bio Products    1:20:00 - Discussion on Skincare Ingredients and Product Application    1:40:00 - The Future of AB Bio and the Importance of Marketing    Guest Information:Guest's Name: Dr. Alena ButkevicaGuest's Title/Position: MD, DMD, PhD, CEO, and Lead ResearcherCompany/Affiliation: AB Bio InnovationsGuest's Bio: Dr. Alena Butkevica is an oro maxillofacial surgeon and the CEO and lead researcher at AB Bio Innovations. With a background in medical science and a passion for helping people, she has created a line of award-winning skincare products that offer scientifically proven solutions for various skin concerns.    

In this episode, we interview Dr. Ethan Perlstein, founder and CEO of Curetopia, about his mission to end rare genetic diseases. Dr. Perlstein shares his journey as a scientist, builder, and investor, and discusses Curetopia's innovative approach to drug development, including the use of blockchain and Web3 technologies. He emphasizes the urgency of addressing rare diseases and the need for new models to accelerate the search for cures.Chapters/Timestamps:00:00 - Introduction and Dr. Ethan Perlstein's Background    08:50 - The Challenge of Rare Diseases    21:25 - Curetopia's Mission and Approach    31:54 - Blockchain and the Future of Drug Development    40:09 - The Future of Curetopia and Rare Disease ResearchGuest Information:Guest's Name: Dr. Ethan PerlsteinGuest's Title/Position: Founder and CEOCompany/Affiliation: CuretopiaGuest's Bio: Dr. Ethan Perlstein is a scientist, builder, and investor with a focus on developing cures for rare genetic diseases. He is the founder and CEO of Curetopia, a company utilizing innovative approaches to drug development and funding.Links and Resources:Curetopia Website: https://www.curetopia.xyz/Curetopia on Telegram: https://t.me/curetopiaCuretopia on X (Twitter): https://x.com/endrarediseasesKey Takeaways/Highlights:Dr. Perlstein's background as a scientist and his transition into building and investing in biotech companies.The challenges and misconceptions surrounding rare diseases, including their prevalence and the lack of financial incentive for research.Dr. Perlstein's motivation for focusing on rare diseases, inspired by his interaction with parents of affected children.Curetopia's mission to end rare diseases through innovative drug development strategies.The potential of blockchain and Web3 technologies to transform drug development, including funding, data sharing, and community engagement.Dr. Perlstein's vision for a more collaborative and accelerated approach to finding cures for rare diseases.

In this episode, we interview Kerchanin Allen, a marketing expert with ten years of experience in the healthcare industry. Kerchanin discusses her journey from journalism to healthcare marketing, sharing insights on the unique challenges and opportunities in this dynamic field. She emphasizes the importance of strategic marketing, storytelling, and adapting to the evolving landscape of healthcare, including the use of AI.Chapters/Timestamps:00:00 - Introduction and Kerchanin Allen's Background    09:02 - Strategic Marketing and Storytelling    21:25 - Marketing to Diverse Audiences    31:54 - AI in Healthcare Marketing    40:09 - Sales and Marketing Alignment    47:04 - Advice for Healthcare Marketers and Final Thoughts    Guest Information:Guest's Name: Kerchanin AllenGuest's Title/Position: Marketing ExpertGuest's Linkedin: https://www.linkedin.com/in/kerchanina/Guest's Bio: Kerchanin Allen is a marketing expert with over ten years of experience implementing marketing strategies for organizations in the healthcare space. Her experience spans payer level, utilization management, care coordination, and ACO REACH.    Key Takeaways/Highlights:Kerchanin Allen's background in journalism and how it informs her approach to marketing.    The importance of strategic versus cosmetic marketing in healthcare.    Challenges and strategies for marketing to diverse audiences (patients, providers, investors).    The role of storytelling and creating cohesive brand narratives.    Navigating compliance and legal considerations in healthcare marketing.    The impact of AI on marketing and its potential in the healthcare sector.    The importance of collaboration between sales and marketing teams.    Advice for healthcare marketers: be adaptable, embrace calculated risks, and be persistent.      

In this episode, we interview Jessica Gibson, CEO and co-founder of Aerial Precision Medicine, about the company's innovative approach to precision medicine. Jessica discusses her journey from studying emergency medicine to leading a company that's using genetics and AI to transform the diagnosis and treatment of chronic diseases. She highlights the importance of addressing the root cause of diseases, the challenges of navigating the healthcare system, and Aerial's work in developing targeted therapies to improve patient outcomes.Chapters/Timestamps:00:00 - Introduction and Jessica Gibson's Background08:50 - Ariel Precision Medicine and its Mission21:25 - The Role of AI and Technology in Precision Medicine31:54 - Addressing Challenges in Healthcare and Drug Development40:09 - Marketing and Collaboration Strategies47:04 - Jessica Gibson's Vision for the Future of Aerial Precision MedicineGuest Information:Guest's Name: Jessica GibsonGuest's Title/Position: CEO and CofounderGuest's Company/Affiliation: Aerial Precision MedicineGuest's Bio: Jessica Gibson is the CEO and co-founder of Aerial Precision Medicine. With a background in medicine and science, she transitioned into business and management to drive innovation in healthcare and improve patient outcomes.Links and Resources:Aerial Precision Medicine Website: https://arielmedicine.com/Jessica Gibson LinkedIn: https://www.linkedin.com/in/jessica-gibson-80426124National Pancreas Foundation: https://nationalpancreasfoundations.org/Rebecca's Wish: https://rebeccaswish.org/Mission Cure: https://mission-cure.org/Key Takeaways/Highlights:Jessica Gibson's journey from emergency medicine and gastroenterology research to leading Aerial Precision Medicine.Aerial Precision Medicine's focus on using genetics and AI to understand the root causes of chronic diseases.The challenges of the "diagnostic odyssey" for patients with digestive and metabolic diseases.How Aerial Precision Medicine's technology helps to streamline the diagnosis process and personalize treatment plans.The importance of data quality and human oversight in the use of AI in healthcare.Aerial Precision Medicine's approach to drug development, starting with a deep understanding of the disease.The company's emphasis on collaboration with healthcare providers, researchers, and pharmaceutical companies.Jessica Gibson's insights on leadership, company growth, and navigating the complexities of the healthcare industry.

In this episode, we interview Joe Banach, Director of Sales and Marketing at Next Step Robotics, about the innovative use of robotics in rehabilitation. Joe shares his unique career path from personal trainer and physical therapist to the health tech industry. He discusses Next Step Robotics' approach to rehabilitation, emphasizing patient contribution to movement and the importance of data-driven outcomes. Joe also provides insights into the challenges of marketing novel technology in the healthcare space and strategies for overcoming them.Chapters/Timestamps:00:00 - Introduction and Joe's Background02:59 - Next Step Robotics and the AMBL Device05:50 - The Role of Data in Therapy09:02 - Sales and Marketing Strategies in Healthcare12:06 - Challenges in Educating the MarketGuest Information:Guest's Name: Joe BanachGuest's Title/Position: Director of Sales and MarketingGuest's Company/Affiliation: Next Step RoboticsGuest's Bio: Joe Banach is the Director of Sales and Marketing at Next Step Robotics. With a background as a physical therapist, Joe is dedicated to advancing rehabilitation through the use of innovative robotic technology and improving patient outcomes.Links and Resources:Next Step Robotics Website: www.nextsteprobo.comLinkedIn: https://www.linkedin.com/in/joseph-banach-pt-dpt-ocs/Book Recommendation: The Sales Acceleration Formula by Mark RobergeBook Recommendation: Never Split The Difference by Chris VossKey Takeaways/Highlights:Joe Banach's unconventional journey from personal trainer to Director of Sales and Marketing.Next Step Robotics' AMBL device and its focus on patient-contributed movement.The importance of supplementing traditional therapy with robotic technology to increase dosage and improve outcomes.The role of neuroplasticity and cognitive engagement in effective rehabilitation.Using data and gamification to motivate patients and track progress.Challenges in educating the market and building trust for new rehabilitation technologies.Sales strategies for navigating long sales cycles and competing in the health tech industry.The impact of therapist turnover on the adoption of new technologies in rehab clinics.

Join host Heath Fletcher on The Healthy Enterprise as he explores how healthcare leaders and innovators are transforming the industry from the inside out. Whether you’re a provider, tech entrepreneur, marketing strategist, or industry executive, these conversations deliver actionable strategies, innovative solutions, and human-centered insights to help you grow, lead, and make a lasting impact.This podcast was created and produced by Bullzeye Media Marketing. Let’s make something great together!